380 related articles for article (PubMed ID: 10235629)
1. CCK2 receptor antagonists: pharmacological tools to study the gastrin-ECL cell-parietal cell axis.
Håkanson R; Ding XQ; Norlén P; Lindström E
Regul Pept; 1999 Mar; 80(1-2):1-12. PubMed ID: 10235629
[TBL] [Abstract][Full Text] [Related]
2. Time-course of deactivation of rat stomach ECL cells following cholecystokinin B/gastrin receptor blockade.
Ding XQ; Lindström E; Håkanson R
Br J Pharmacol; 1997 Sep; 122(1):1-6. PubMed ID: 9298521
[TBL] [Abstract][Full Text] [Related]
3. Cholecystokinin-B/gastrin receptor blockade suppresses the activity of rat stomach ECL cells.
Ding XQ; Lindström E; Håkanson R
Pharmacol Toxicol; 1997 Jul; 81(1):19-25. PubMed ID: 9258980
[TBL] [Abstract][Full Text] [Related]
4. Effect of cholecystokinin-2 receptor blockade on rat stomach ECL cells. A histochemical, electron-microscopic and chemical study.
Chen D; Zhao CM; Norlén P; Björkqvist M; Ding XQ; Kitano M; Håkanson R
Cell Tissue Res; 2000 Jan; 299(1):81-95. PubMed ID: 10654072
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of three novel cholecystokinin-B/gastrin receptor antagonists: a study of their effects on rat stomach enterochromaffin-like cell activity.
Ding XQ; Lindström E; Håkanson R
Pharmacol Toxicol; 1997 Nov; 81(5):232-7. PubMed ID: 9396089
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological analysis of CCK2 receptor antagonists using isolated rat stomach ECL cells.
Lindström E; Björkqvist M; Håkanson R
Br J Pharmacol; 1999 May; 127(2):530-6. PubMed ID: 10385255
[TBL] [Abstract][Full Text] [Related]
7. Reversibility of cholecystokinin-B/gastrin receptor blockade: a study of the gastrin-ECL cell axis in the rat.
Norlén P; Lindström E; Ding XQ; Kitano M; Håkanson R
Pharmacol Toxicol; 1999 Apr; 84(4):159-64. PubMed ID: 10227066
[TBL] [Abstract][Full Text] [Related]
8. Long-lasting cholecystokinin(2) receptor blockade after a single subcutaneous injection of YF476 or YM022.
Kitano M; Norlén P; Ding XQ; Nakamura S; Håkanson R
Br J Pharmacol; 2000 Jun; 130(3):699-705. PubMed ID: 10821801
[TBL] [Abstract][Full Text] [Related]
9. Functional impairment of the individual rat stomach ECL cell in response to sustained hypergastrinemia.
Kimura K; Chen D; Lindström E; Yamada H; Zhao CM; Håkanson R
Regul Pept; 1997 Oct; 72(2-3):69-77. PubMed ID: 9652979
[TBL] [Abstract][Full Text] [Related]
10. Role of gastrin in the development of gastric mucosa, ECL cells and A-like cells in newborn and young rats.
Björkqvist M; Dornonville de la Cour C; Zhao CM; Gagnemo-Persson R; Håkanson R; Norlén P
Regul Pept; 2002 Oct; 108(2-3):73-82. PubMed ID: 12220729
[TBL] [Abstract][Full Text] [Related]
11. Gastric submucosal microdialysis: a method to study gastrin- and food-evoked mobilization of ECL-cell histamine in conscious rats.
Kitano M; Norlén P; Håkanson R
Regul Pept; 2000 Jan; 86(1-3):113-23. PubMed ID: 10672910
[TBL] [Abstract][Full Text] [Related]
12. Gastrin-evoked secretion of pancreastatin and histamine from ECL cells and of acid from parietal cells in isolated, vascularly perfused rat stomach. Effects of isobutyl methylxanthin and alpha-fluoromethylhistidine.
Chen D; Mårvik R; Rønning K; Andersson K; Waldum HL; Håkanson R
Regul Pept; 1996 Sep; 65(2):133-8. PubMed ID: 8884980
[TBL] [Abstract][Full Text] [Related]
13. Evidence that peroral calcium does not activate the gastrin-ECL-cell axis in the rat.
Survé VV; Håkanson R
Regul Pept; 1998 Feb; 73(3):177-82. PubMed ID: 9556080
[TBL] [Abstract][Full Text] [Related]
14. Sustained cholecystokinin-B/gastrin receptor blockade does not impair basal or histamine-stimulated acid secretion in chronic gastric fistula rats.
Ding XQ; Kitano M; Håkanson R
Pharmacol Toxicol; 1998 Apr; 82(4):177-82. PubMed ID: 9584331
[TBL] [Abstract][Full Text] [Related]
15. Control of gastric acid secretion:the gastrin-ECL cell-parietal cell axis.
Lindström E; Chen D; Norlén P; Andersson K; Håkanson R
Comp Biochem Physiol A Mol Integr Physiol; 2001 Mar; 128(3):505-14. PubMed ID: 11246041
[TBL] [Abstract][Full Text] [Related]
16. Altered influence of CCK-B/gastrin receptors on HDC expression in ECL cells after neoplastic transformation.
Kölby L; Wängberg B; Ahlman H; Modlin IM; Theodorsson E; Nilsson O
Regul Pept; 1999 Dec; 85(2-3):115-23. PubMed ID: 10651065
[TBL] [Abstract][Full Text] [Related]
17. Histidine decarboxylase expression and histamine metabolism in gastric oxyntic mucosa during hypergastrinemia and carcinoid tumor formation.
Kölby L; Wängberg B; Ahlman H; Modlin IM; Granérus G; Theodorsson E; Nilsson O
Endocrinology; 1996 Oct; 137(10):4435-42. PubMed ID: 8828505
[TBL] [Abstract][Full Text] [Related]
18. Acute responses of rat stomach enterochromaffinlike cells to gastrin: secretory activation and adaptation.
Chen D; Monstein HJ; Nylander AG; Zhao CM; Sundler F; Håkanson R
Gastroenterology; 1994 Jul; 107(1):18-27. PubMed ID: 7517373
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the specificity and potency of a series of cholecystokinin-B/gastrin receptor antagonists in vivo.
Ding XQ; Håkanson R
Pharmacol Toxicol; 1996 Sep; 79(3):124-30. PubMed ID: 8884870
[TBL] [Abstract][Full Text] [Related]
20. Effect of cholecystokinin-B/gastrin receptor blockade on gastric acid secretion in conscious rats.
Ding XQ; Håkanson R
Pharmacol Toxicol; 1996 Dec; 79(6):324-30. PubMed ID: 9000260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
